{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:34:58Z","timestamp":1789824898583,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T00:00:00Z","timestamp":1464048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10792-016-0260-1","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T16:20:43Z","timestamp":1464106843000},"page":"245-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ganciclovir ophthalmic gel treatment shortens the recovery time and prevents complications in the adenoviral eye infection"],"prefix":"10.1007","volume":"37","author":[{"given":"Serkan","family":"Ozen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat A.","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,24]]},"reference":[{"key":"260_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10384-010-0894-x","volume":"55","author":"K Aoki","year":"2011","unstructured":"Aoki K, Kaneko H, Nobuyoshi Kitaichi N et al (2011) Clinical features of adenoviral conjunctivitis at the early stage of infection. Jpn J Ophthalmol 55:11\u201315","journal-title":"Jpn J Ophthalmol"},{"key":"260_CR2","first-page":"213","volume-title":"Family adenoviridae. Virus taxonomy. VIIIth report of the International Committee on Taxonomy of Viruses","author":"M Benko","year":"2005","unstructured":"Benko M, Harrach B, Both GW et al (2005) Family adenoviridae. Virus taxonomy. VIIIth report of the International Committee on Taxonomy of Viruses. Elsevier, New York, pp 213\u2013228"},{"issue":"4","key":"260_CR3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/112067211002000404","volume":"20","author":"R Ya\u011fci","year":"2010","unstructured":"Ya\u011fci R, Ak\u00e7ali A, Ya\u011fci S et al (2010) Molecular identification of adenoviral conjunctivitis in Turkey. Eur J Ophthalmol 20(4):669\u2013674","journal-title":"Eur J Ophthalmol"},{"key":"260_CR4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9394(14)70640-3","volume":"121","author":"MJ Azar","year":"1996","unstructured":"Azar MJ, Dhaliwal DK, Bower KS, Kowalski RP, Gordon YJ (1996) Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol 121:711\u2013712","journal-title":"Am J Ophthalmol"},{"key":"260_CR5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0161-6420(02)00992-2","volume":"109","author":"J Hillenkamp","year":"2002","unstructured":"Hillenkamp J, Reinhard T, Ross RS et al (2002) The effects of cidofovir 1\u00a0% with and without cyclosporin a 1\u00a0% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology 109:845\u2013850","journal-title":"Ophthalmology"},{"key":"260_CR6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jac\/dki057","volume":"55","author":"PR Kinchington","year":"2005","unstructured":"Kinchington PR, Romanowski EG, Gordon YJ (2005) Prospects for adenoviral antivirals. J Antimicrob Chemother 55:424\u2013429","journal-title":"J Antimicrob Chemother"},{"key":"260_CR7","first-page":"S579","volume":"42","author":"KF Tabbara","year":"2001","unstructured":"Tabbara KF, Jarade EF (2001) Ganciclovir effects in adenoviral keratoconjunctivitis [abstract 3111-B253]. ARVO 42:S579","journal-title":"ARVO"},{"key":"260_CR8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ICU.0b013e3283477cb5","volume":"22","author":"HE Kaufman","year":"2011","unstructured":"Kaufman HE (2011) Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol 22:290\u2013293","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"260_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.optom.2012.08.003","volume":"6","author":"AM Pihos","year":"2013","unstructured":"Pihos AM (2013) Epidemic keratoconjunctivitis: a review of current concepts in management. J Optom 6(2):69\u201374","journal-title":"J Optom"},{"issue":"6","key":"260_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1590\/S0004-27492011000600007","volume":"74","author":"ST Yabiku","year":"2011","unstructured":"Yabiku ST, Yabiku MM, Bott\u00f3s KM, Ara\u00fajo AL, Freitas Dd, Belfort R Jr (2011) Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis. Arq Bras Oftalmol 74(6):417\u2013421","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"260_CR11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.17925\/USOR.2012.05.02.100","volume":"5","author":"J Affeldt","year":"2012","unstructured":"Affeldt J, Gadaria-Rathod N, Fernandez KB, Asbell P (2012) Ganciclovir in the treatment of ophthalmic viral infections\u2014case reports. US Ophthalmic Rev 5(2):100\u2013104","journal-title":"US Ophthalmic Rev"},{"issue":"3","key":"260_CR12","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AAC.49.3.1010-1016.2005","volume":"49","author":"G Naesens","year":"2005","unstructured":"Naesens G, Lenaerts L, Andrei G, Snoeck R, Van Beers D, Holy A (2005) Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother 49(3):1010\u20131016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"260_CR13","first-page":"441","volume":"1","author":"J Colin","year":"2007","unstructured":"Colin J (2007) Ganciclovir ophthalmic gel, 00:15%: a valuable tool for treating ocular herpes. Clin Ophthalmol 1(4):441\u2013453","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"260_CR14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00003495-199448030-00009","volume":"48","author":"A Markham","year":"1994","unstructured":"Markham A, Faulds D (1994) Gancyclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs 48(3):455\u2013484","journal-title":"Drugs"},{"key":"260_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.ico.0000170693.13326.fb","volume":"25","author":"AL Butt","year":"2006","unstructured":"Butt AL, Chodosh J (2006) Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea 25:199\u2013202","journal-title":"Cornea"},{"key":"260_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12009-000-0085-3","volume":"32","author":"RP Kowalski","year":"2000","unstructured":"Kowalski RP, Foulks GN, Gordon YJ (2000) An overview comparing treatment regimens for ocular infections: community versus academia. Ann Ophthalmol 32:295\u2013300","journal-title":"Ann Ophthalmol"},{"key":"260_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","volume":"18","author":"L Lenaerts","year":"2008","unstructured":"Lenaerts L, De Clercq E, Naesens L (2008) Clinical features and treatment of adenovirus infections. Rev Med Virol 18:357\u2013374","journal-title":"Rev Med Virol"},{"key":"260_CR18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4321\/S0365-66912006000900001","volume":"81","author":"J Rajaiya","year":"2006","unstructured":"Rajaiya J, Chodosh J (2006) New paradigms in infectious eye disease: adenoviral keratoconjunctivitis. Arch Soc Esp Oftalmol 81:493\u2013498","journal-title":"Arch Soc Esp Oftalmol"},{"key":"260_CR19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-009-0062-1","volume":"26","author":"JS Pelletier","year":"2009","unstructured":"Pelletier JS, Stewart K, Trattler W et al (2009) A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther 26:776\u2013783","journal-title":"Adv Ther"},{"key":"260_CR20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/archopht.116.7.900","volume":"116","author":"YJ Gordon","year":"1998","unstructured":"Gordon YJ, Araullo-Cruz T, Romanowski EG (1998) The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication. Arch Ophthalmol 116:900\u2013905","journal-title":"Arch Ophthalmol"},{"key":"260_CR21","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0161-6420(00)00177-9","volume":"107","author":"Y Shiuey","year":"2000","unstructured":"Shiuey Y, Ambati BK, Adamis AP et al (2000) A randomized, double-masked trial of topical ketorolac versus artificial tears from treatment of viral conjunctivitis. Ophthalmology 107:1512\u20131517","journal-title":"Ophthalmology"},{"key":"260_CR22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ico.0000127481.23714.b6","volume":"24","author":"EG Romanowski","year":"2005","unstructured":"Romanowski EG, Pless P, Yates KA et al (2005) Topical cyclosporine A inhibits subepithelial infiltrates but also promotes viral shedding in experimental adenovirus models. Cornea 24:86\u201391","journal-title":"Cornea"},{"key":"260_CR23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00003226-200108000-00020","volume":"20","author":"EG Romanowski","year":"2001","unstructured":"Romanowski EG, Yates KA, Gordon YJ (2001) Short-term treatment with a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit. Cornea 20:657\u2013660","journal-title":"Cornea"},{"issue":"3","key":"260_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-3542(95)00962-0","volume":"31","author":"B Oliveira de","year":"1996","unstructured":"de Oliveira B, Stevenson D, LaBree L, McDonnel PJ, Trousdale MD (1996) Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antivir Res 31(3):165\u2013172","journal-title":"Antivir Res"},{"issue":"9","key":"260_CR25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00417-006-0523-z","volume":"245","author":"E Uchio","year":"2007","unstructured":"Uchio E, Fuchigami A, Kadonosono K et al (2007) Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 245(9):1319\u20131325","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"260_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bjo.80.2.140","volume":"80","author":"HB Hoh","year":"1996","unstructured":"Hoh HB, Hurley C, Claoue C et al (1996) Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study. Br J Ophthalmol 80(2):140\u2013143","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"260_CR27","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.ophtha.2005.02.004","volume":"112","author":"KF Tabbara","year":"2005","unstructured":"Tabbara KF (2005) Treatment of herpetic keratitis. Ophthalmology 112(9):1640","journal-title":"Ophthalmology"},{"key":"260_CR28","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bmt.1700997","volume":"20","author":"FE Chen","year":"1997","unstructured":"Chen FE, Liang RH, Lo JY et al (1997) Treatment of adenovirus associated haemorrhagic cystitis with ganciclovir. Bone Marrow Transpl 20:997\u2013999","journal-title":"Bone Marrow Transpl"},{"key":"260_CR29","first-page":"315","volume":"8","author":"J Huang","year":"2014","unstructured":"Huang J, Kadonosono K, Uchio E (2014) Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods. Clin Ophthalmol 8:315\u2013320","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"260_CR30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1067\/mic.2002.125193","volume":"30","author":"E Piednoir","year":"2002","unstructured":"Piednoir E, Bureau-Chalot F, Merle C, Gotzamanis A, Wuiboult J, Bajolet O (2002) Direct costs associated with a nosocomial outbreak of adenoviral conjunctivitis infection in a long-term care institution. Am J Infect Control 30(7):407\u2013410","journal-title":"Am J Infect Control"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-016-0260-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0260-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0260-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T19:22:44Z","timestamp":1567970564000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-016-0260-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1007\/s10792-016-0260-1","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,24]]}}}